Safilo Group S.p.A. (SAFLY)
OTCMKTS · Delayed Price · Currency is USD
2.290
+0.060 (2.69%)
At close: Jul 1, 2025
Safilo Group Market Cap
Safilo Group has a market cap or net worth of $583.50 million as of August 1, 2025. Its market cap has increased by 23.01% in one year.
Market Cap
583.50M
Enterprise Value
647.08M
Revenue
1.17B
Ranking
n/a
PE Ratio
10.71
Stock Price
$2.29
Market Cap Chart
Since December 9, 2005, Safilo Group's market cap has decreased from 743.66M to 583.50M, a decrease of -21.54%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 583.50M | 45.67% |
| Dec 30, 2024 | 400.57M | -4.17% |
| Dec 29, 2023 | 418.00M | -37.88% |
| Dec 30, 2022 | 672.90M | -8.70% |
| Dec 30, 2021 | 737.02M | 172.96% |
| Dec 30, 2020 | 270.01M | -21.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |